Status:
COMPLETED
Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablation
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
50-75 years
Brief Summary
The purpose of this study is to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome To evaluate the inflammatory activation following catheter...
Detailed Description
Specific Aim: The purpose of this prospective study is to evaluate the role of inflammatory biomarkers in predicting procedure-outcome in AF patients undergoing catheter ablation. Background: AF is t...
Eligibility Criteria
Inclusion
- Age: 50-70 years
- Patients undergoing catheter ablation of atrial fibrillation
- Able and willing to give written consent
Exclusion
- Reversible causes of AF such as pericarditis and hyperthyroidism
- Associated chronic inflammatory diseases such as chronic gingivitis or peri-odontitis, rheumatoid Arthritis, IBD including Ulcerative Colitis and Crohn's disease, Lupus, Ankylosing Spondylitis, COPD, psoriasis, vasculitis
- Any other co-morbid conditions except Diabetes and hypertension
- Patients taking long-term anti-inflammatory, steroid medication, or immune suppression medication.
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT02208102
Start Date
July 1 2014
End Date
May 1 2016
Last Update
October 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Cardiac Arrhythmia Institute, St. david's Medical Center
Austin, Texas, United States, 78727